Macular Society launches second training course for eye care professionals

Macular Society logo

10 May 2019
Source: Macular Society

Leading sight loss charity the Macular Society has given a boost to eye care professionals wanting to learn more about macular disease by launching a brand-new free course to its online training package. ‘The emotional impact of a diagnosis of AMD’ is the second course it has made available through the web-based training programme. Alongside the first course, ‘An Introduction

Read more Macular Society launches second training course for eye care professionals

BBC News: Gene therapy first to ‘halt’ AMD the most common cause of blindness

19 February 2019
Source: BBC News

A woman from Oxford has become the first person in the world to have gene therapy to try to halt the most common form of blindness in the Western world. Surgeons injected a synthetic gene into the back of Janet Osborne’s eye in a bid to prevent more cells from dying. It is the first treatment to target the underlying

Read more BBC News: Gene therapy first to ‘halt’ AMD the most common cause of blindness

Macular degeneration trial will be first human test of Nobel-winning stem cell technique

18 January 2019
Source: STAT

Curing diabetes with stem cells? Everyone knew that would be hard. Parkinson’s disease? Harder. Alzheimer’s? Probably impossible. But age-related macular degeneration, a major cause of blindness? That was supposed to be low-hanging fruit. The cause of AMD is well-known, the recipe for turning stem cells into retinal cells works like a charm, and the eye is “immunoprivileged,” meaning immune cells

Read more Macular degeneration trial will be first human test of Nobel-winning stem cell technique

ABDO: Macular Society: Nearly 1.5m people in the UK affected by biggest cause of blindness

9 November 2018
Source: ABDO

New figures have revealed that nearly 1.5m people in the UK are affected by macular disease, the nation’s biggest cause of blindness. The statistics revealed by national sight loss charity, the Macular Society, have been released on World Sight Day to highlight the extent of what is now an urgent public health issue. Macular disease is a progressive disease, which

Read more ABDO: Macular Society: Nearly 1.5m people in the UK affected by biggest cause of blindness

Nearly 1.5m people in the UK affected by biggest cause of blindness

Macular Society logo

11 October 2018

New figures have revealed that nearly 1.5m[i] people in the UK are affected by macular disease, the nation’s biggest cause of blindness. The statistics revealed by national sight loss charity, the Macular Society, have been released on World Sight Day to highlight the extent of what is now an urgent public health issue. Macular disease is a progressive disease, which

Read more Nearly 1.5m people in the UK affected by biggest cause of blindness

Serious eye disorders. Consultation on draft quality standard, joint submisison from The Royal College of Ophthalmologists with The College of Optometrists and Vision UK

2 October 2018

This quality standard will cover the diagnosis and management of serious eye conditions in adults including cataracts, glaucoma and macular degeneration. It will also cover preventing sight loss in adults. This quality standard will replace the existing NICE quality standard for Glaucoma in adults (QS7). The topic was identified for update following the annual review of quality standards in 2017.

Read more Serious eye disorders. Consultation on draft quality standard, joint submisison from The Royal College of Ophthalmologists with The College of Optometrists and Vision UK
NICE QS Chronic Disease Joint Response With RCOphth COO And Vision UK V1.4
NICE QS Chronic Disease Joint Response With RCOphth COO And Vision UK V1.4
Download pdf 0.7 MB

Macular Society, National Eye Health Week – Could our immune system be causing AMD?

28 September 2018
Source: Macular Society

Imagine not being able to read the newspaper, or enjoy the autumn flowers in the garden? Imagine seeing fuzzy images and blurred lines? This is what people living with Macular Degeneration, or AMD, deal with every day. In the UK, around 600,000 people are living with AMD and around 70,000 new cases are diagnosed every year: that’s nearly 200 every

Read more Macular Society, National Eye Health Week – Could our immune system be causing AMD?

BBC News: NHS to save ‘hundreds of millions’ in landmark (Avsatin) drug ruling

21 September 2018
Source: BBC News

A landmark ruling against two leading drug companies could save the NHS “hundreds of millions” a year. Novartis and Bayer were trying to stop NHS doctors from prescribing a cheaper treatment for a serious eye condition. Twelve NHS bodies in the north east of England were offering patients Avastin, a cheaper alternative to the licensed drug, Lucentis. Health bosses said

Read more BBC News: NHS to save ‘hundreds of millions’ in landmark (Avsatin) drug ruling

Macular Society to hold Professional Conference in October

25 July 2018
Source: Macular Society

The Macular Society will hold its third Professional Conference in October. Tickets are  now available for the event, ‘Excellence in Patient Support’, which takes place on Tuesday 16 October at Conference Aston, Aston University, Birmingham. The conference is open to all staff working in the eye care sector. It will focus on the latest in macular treatments, NICE guidelines, the

Read more Macular Society to hold Professional Conference in October

Researchers are one step closer to developing eye drops to treat common sight loss condition

23 July 2018
Source: University of Birmingham

Scientists at the University of Birmingham are one step closer to developing an eye drop that could revolutionise treatment for age-related macular degeneration (AMD). AMD is the leading cause of blindness in the developed world. Its prevalence is increasing dramatically as the population ages and it is estimated that, by 2020, there will be about 200 million people worldwide with

Read more Researchers are one step closer to developing eye drops to treat common sight loss condition